The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bermingham Nessan since 2017.
The trader's CIK number is 1377759.
At the time of the last reporting, Bermingham Nessan was the President & CEO of Intellia Therapeutics, Inc.. (stock ticker symbol NTLA).
Also see all insider trading activities at Intellia Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | NTLA | 0 | $0 | 336,783 | $7,039,728 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-12-08 | NTLA | Sale | 94,143 | 20.82 | 1,960,151 |
| 2017-12-07 | NTLA | Sale | 131,140 | 21.25 | 2,787,249 |
| 2017-12-06 | NTLA | Sale | 111,500 | 20.56 | 2,292,328 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bermingham Nessan (President & CEO of Intellia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.